Full-Time

Healthcare Sales Director

Adaptive Linacs, Northeast Region

Posted on 12/13/2025

Elekta

Elekta

1,001-5,000 employees

Delivers precision radiation therapy equipment

Compensation Overview

$145k - $155k/yr

+ Car Allowance

Company Does Not Provide H1B Sponsorship

Georgia, USA

In Person

Category
Sales & Account Management (2)
,
Required Skills
Sales
Requirements
  • Bachelor’s Degree (clinical or business oriented) or equivalent knowledge acquired through business experience.
  • Demonstrable business acumen, commercial and analytical mindset.
  • Successful sales and negotiation experience. Capital medical equipment sales experience is highly meritorious.
  • Ideally skills in Physics (diploma physicist or dosimetry, or knowledge of medical physics), and/or competences in hospital information systems and treatment planning systems.
  • Solid knowledge and experience of the medical devices industry, MR imaging experience and knowledge is preferred.
  • Excellent communication skills, both written and verbal. Skilled speaker and representative in social contacts.
  • Strong multi-tasker and experience covering a broader region (along with all the travel it requires).
  • Fluency in English is required, preferably also another language relevant to the Region.
  • Comprehensive knowledge of computer tools / IT skills.
  • Ability to work autonomously.
  • Excellent team player at all levels and strong interpersonal skills.
  • Strong knowledge/understanding of Elekta's product portfolio.
  • Self-Driven with a demonstrable high-level of engagement and enthusiasm.
  • Strong in building and maintaining customer focus and customer relationships.
  • Results oriented, operative with excellent analytical skills.
  • Strong ethical standards, values and good judgement.
  • Proactive, Persistent, enduring and prepared to make strong personal commitments.
Responsibilities
  • Identify sales opportunities into existing customer sites and into to new sites in close collaboration with the local Zone sales teams.
  • Implement given actions to achieve the sales goals defined by the commercial lead of each project.
  • Support the Zone sales team with in-depth product expertise.
  • Maximize the Elekta market share by facilitation bundle deals across the entire portfolio whenever possible.
  • Make product and sales presentations when required.
  • Consult and give advice of how to best find a suitable MR Linac location in a hospital and suitable delivery pathways.
  • Review and support the full utilization and adoption of CLM in the relevant geography.
  • To implement regional sales and marketing plans for Adaptive Linacs by driving specific programs, respectively coordinating and supporting country-specific sales activities and programs.
  • To provide input regarding regional product and promotional requirements for Adaptive Linacs.
  • To support customer’s Adaptive Linac programs through effective coordination of company resources.
  • Attend and represent Elekta at conferences, symposiums, shows and other events as required.
  • Responsible for maintaining all tools placed at its disposal by Elekta such as telephone, PC, etc.
  • Develop, implement, maintain and follow Quality procedures as they pertain to company policy.
  • Drive efficiency programs identified by self or others within Elekta.
  • Incorporate Elekta Values into all departmental functions and responsibilities.
  • Promote continuous improvement and be a change agent.
  • Perform other related duties as assigned or requested.
  • To propose pricing, configurations and solutions for CT/MR Linacs and associated services and products to the customers.
  • To take decisions in order to secure sales within the company guidelines.
Desired Qualifications
  • Capital medical equipment sales experience is highly meritorious.
  • Fluency in English is required, preferably also another language relevant to the Region is preferred.

Elekta specializes in precision radiation medicine, delivering devices and software that help clinicians treat cancer and brain disorders. Its core products are radiation therapy equipment (such as linear accelerators and advanced radiosurgery platforms) and treatment-planning and clinical workflow software. These tools work together: the hardware delivers targeted ionizing radiation to tumors while imaging and planning software optimize dose exactly where it is needed, then guide clinicians through the treatment workflow. Elekta differentiates itself by offering an integrated hardware-software ecosystem with a global installed base, a focus on reaching underserved markets, and ongoing services to support clinicians and facilities. The company's goal is to improve patient outcomes by expanding access to high-quality radiation therapy and growing its installed base around the world.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Stockholms kommun, Sweden

Founded

1972

Simplify Jobs

Simplify's Take

What believers are saying

  • Elekta grows 2% revenue in Q3 2026 with 1.17 book-to-bill ratio.
  • FDA clearance for Evo CT-Linac expands US oncology market access.
  • Nexeva partnership strengthens South Africa radiotherapy infrastructure.

What critics are saying

  • 0apt ransomware steals radiotherapy algorithms on February 4, 2026.
  • Varian erodes 6% Americas sales via superior Ethos integration.
  • $8.9M settlement from 2021 breach exposes cybersecurity negligence.

What makes Elekta unique

  • Elekta leads in MR-Linac with Elekta Unity for precise tumor targeting.
  • Elekta dominates brachytherapy post-2011 Nucletron acquisition.
  • Elekta's Harmony linac and 2024 Evo CT-Linac enhance precision radiation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Paid Vacation

Hybrid Work Options

Wellness Program

Tuition Reimbursement

Company News

Yahoo Finance
Mar 5th, 2026
Elekta posts 2% revenue growth, $42.6M restructuring charge amid $504M currency headwinds

Elekta AB reported 2% revenue growth in Q3 2026, with gross margin improving 120 basis points to 38.3% and EBIT margin rising to 11.9%. The company achieved a book-to-bill ratio of 1.17, supported by strong momentum in Europe and growth in China. However, the quarter was significantly impacted by foreign exchange headwinds, with currency reducing net sales by over SEK500 million. The Americas region experienced a 6% sales decline. Elekta incurred restructuring charges exceeding SEK400 million but expects total costs under SEK500 million, with run-rate savings of over SEK500 million from Q1 next year. Net debt decreased by more than SEK200 million year-on-year. The company successfully launched Elekta Evo in the US and maintains leadership in China's underpenetrated radiotherapy market.

Bizcommunity
Mar 3rd, 2026
Elekta appoints Nexeva Healthcare Solutions as strategic partner in South Africa

Elekta appoints Nexeva Healthcare Solutions as strategic partner in South Africa. Enhanced local service model to strengthen radiotherapy support, clinical capability and lifecycle management 3 Mar 2026 The agreement between Elekta and Nexeva Healthcare Solutions was formalised during the World Health Expo held in Dubai in February 2026. Back row (left to right): Ozgur Temel, head of sub-Saharan Africa at Elekta; Laurent Leksell, chairman of the board, Elekta; Marga Claassen, medical physicist and regional sales manager at Nexeva; Tomas Eliasson, vice chair of the board; Anthony Pedersen, CEO, Icon Healthcare Holdings. Front (seated): Simon Meredith, managing director Nexeva Healthcare Solutions; Feras Al Hassan, VP service and sales operations, Elekta. Elekta has appointed Nexeva Healthcare Solutions as its strategic partner in South Africa under a multi-year agreement. The appointment introduces a strengthened local operating model designed to enhance technical support, clinical engagement and commercial responsiveness for radiotherapy centres across both the private and public healthcare sectors. The agreement was formally signed during the World Health Expo in Dubai in February 2026, underscoring the strategic importance of the South African market within Elekta's broader regional framework. The signing brought together senior leadership from both organisations, reinforcing the long-term nature of the collaboration and its focus on strengthening radiotherapy delivery capacity across South Africa. Strengthening radiotherapy infrastructure. South Africa's oncology sector continues to operate under significant capacity pressure, where uptime, service responsiveness and access to clinical training are critical. The Elekta - Nexeva collaboration combines Elekta's global radiotherapy innovation and standards with Nexeva's established local healthcare footprint and service capability. Under the agreement, customers can expect: * Expanded field service engineering capacity in South Africa * Enhanced commercial and technical support * Closer clinical engagement, including applications and training support * Continued focus on installations, commissioning, upgrades and lifecycle management The partnership is structured to improve response times, strengthen local accountability and support long-term sustainability of radiotherapy services in the region. Elekta will maintain a lean, focused local team in South Africa, working in alignment with Nexeva to support customers and partners. Continuity of standards and patient safety. Elekta confirmed that equipment standards, quality systems and patient safety commitments remain unchanged. Nexeva will operate in full alignment with Elekta's global processes and performance standards, ensuring continuity across service, clinical support and commercial engagement. Simon Meredith, managing director at Nexeva Healthcare Solutions, said the appointment reflects a strategic commitment to strengthening oncology infrastructure in South Africa. "Radiotherapy centres operate in high-demand environments where reliability and rapid response are essential. This partnership enables us to combine Elekta's globally recognised technology with an agile, locally embedded support model that is responsive to the realities of South African healthcare." "Our priority is to work closely with clinical and technical teams to minimise downtime, strengthen capability through training and applications support, and ensure long-term lifecycle optimisation of installed systems." Meredith added that the collaboration is designed to support both immediate operational needs and future market development aligned to South Africa's radiotherapy priorities. Transition and implementation. Elekta and Nexeva have already engaged with customers to confirm commercial and technical points of contact, service pathways, escalation processes and alignment on planned installations, upgrades and training schedules. The multi-year agreement signals a long-term commitment to strengthening radiotherapy delivery capacity in South Africa, with a clear focus on service resilience, clinical partnership and sustainable growth. About elekta. As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com. About Nexeva Healthcare Solutions. Nexeva Healthcare Solutions is a South African healthcare solutions provider delivering innovative medical technologies and integrated support services. By combining trusted global innovations with agile local service, Nexeva supports healthcare providers in achieving optimal patient outcomes. Nexeva Health Solutions is a South African MedTech company committed to strengthening healthcare performance through high-quality technologies, responsive service, and clinical support. We partner with leading global manufacturers to bring proven innovations into the local market, ensuring clinicians have access to reliable, cost-effective solutions that enhance precision, efficiency, and continuity of care. Backed by Icon Healthcare's two-decade legacy in value-based care, Nexeva combines deep local expertise with a strong understanding of clinical workflows. Our team supports healthcare providers with integration, training, and ongoing technical service, expanding access to technologies that improve outcomes and enable sustainable, patient-centred healthcare across South Africa.

Yahoo Finance
Jan 19th, 2026
Elekta wins FDA clearance for Evo CT-Linac, expanding US radiation oncology offering

Elekta has received FDA 510(k) clearance for its Elekta Evo CT-Linac system, enabling its use across United States radiation oncology centres. The system combines high-quality CT imaging with linear accelerator functionality, allowing clinicians to visualise tumours and organs-at-risk more clearly during treatment. Evo features Iris, an AI-enhanced imaging capability that uses algorithms to minimise scatter and improve image reconstruction compared to traditional cone-beam CT imaging. The technology can be added as an upgrade to existing Elekta linear accelerators, extending their useful life whilst lowering adoption barriers. The system is already being used in Europe and other regions. Shares of Elekta rose 3.7% following the announcement, with the stock gaining 38.4% over the past six months.

DOTmed.com, Inc.
Sep 15th, 2025
Elekta appoints new CFO as part of broader leadership overhaul

Elekta has announced a series of leadership changes, including the appointment of Klara Eiritz as chief financial officer.

Gray Oncology Solutions
Jul 7th, 2025
Elekta and Gray partner to offer optimized oncology appointment scheduling for Elekta ONE OIS customers

Gray Oncology Solutions is proud to announce a new partnership with Elekta, a global leader in precision radiation medicine, to bring its Care Orchestration Platform, GrayOS, to Elekta ONE OIS customers across North America.

INACTIVE